Andesa Financial Management Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Andesa Financial Management Inc.

  • $338 Million
  • Q1 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 27, 2022
SELL
$548.35 - $738.84 $185,890 - $250,466
-339 Closed
0 $0
Q1 2022

May 09, 2022
BUY
$595.12 - $698.43 $201,745 - $236,767
339 New
339 $236,000
Q3 2020

Nov 09, 2020
SELL
$544.75 - $658.21 $187,938 - $227,082
-345 Closed
0 $0
Q2 2020

Aug 07, 2020
BUY
$493.32 - $643.92 $170,195 - $222,152
345 New
345 $213,000

Others Institutions Holding REGN

# of Institutions
1,529
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Andesa Financial Management Inc. Portfolio

Follow Andesa Financial Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Andesa Financial Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Andesa Financial Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email